Suppr超能文献

格雷夫斯眼病患者的甲状腺结合抗体及其他免疫异常:环磷酰胺治疗的效果

Thyroid binding antibodies and other immunological abnormalities in patients with Graves' ophthalmopathy: effect of treatment with cyclophosphamide.

作者信息

Wall J R, Strakosch C R, Fang S L, Ingbar S H, Braverman L E

出版信息

Clin Endocrinol (Oxf). 1979 Jan;10(1):79-91. doi: 10.1111/j.1365-2265.1979.tb03036.x.

Abstract

Patients with Graves' ophthalmopathy were studied for a possible role of thyroid binding antibodies (TBAb) as measured by a radioreceptor assay, and for in vitro evidence of immunoreactivity to orbital antigens. The effect of cyclophosphamide (CY) treatment on the immunological parameters and the clinical course of the eye disease was also studied. The mean TBAb index for all patients with eye disease was significantly less than that for the normal and for patients with Graves hyperthyroidism who lacked eye disease. The mean TBAb index for patients with ophthalmopathy and past or present hyperthyroidism was significantly less than for those patients with eye disease but no associated hyperthyroidism ('euthyroid Graves' disease'). TBAb levels did not correlate with the severity of duration of the eye disease and did not change during treatment with CY. Significant titres of serum antibodies against human eye muscle extract or subcellular fractions, or macrophage inhibitory factor (MIF) production in response to human orbital tissue extract were not detected in patients with eye disease. The congestive changes improved in all patients treated with CY, although the degree of proptosis and eye muscle involvement improved in only 3 of 24 and 11 of 20 patients respectively with these abnormalities. TBAb are unlikely to play a role in the pathogenesis of Graves' ophthalmopathy and the hyperthyroidism and eye disease should be considered separate autoimmune disorders. The apparently anomalous finding of a higher mean TBAb index in patients with eye disease and hyperthyroidism than in those with hyperthyroidiam alone may reflect a more severe defect of suppressor T cell function in the former group. Because evidence for specific immunoreactivity against orbital antigens was not found in this study other approaches to defining the underlying immunological mechanisms will have to be sought.

摘要

对患有格雷夫斯眼病的患者进行了研究,以探讨通过放射受体测定法测量的甲状腺结合抗体(TBAb)可能发挥的作用,以及对眼眶抗原免疫反应性的体外证据。还研究了环磷酰胺(CY)治疗对免疫参数和眼部疾病临床进程的影响。所有眼病患者的平均TBAb指数显著低于正常人和无眼病的格雷夫斯甲亢患者。有眼病且有既往或当前甲亢的患者的平均TBAb指数显著低于有眼病但无相关甲亢(“甲状腺功能正常的格雷夫斯病”)的患者。TBAb水平与眼病的严重程度或病程无关,且在CY治疗期间没有变化。眼病患者未检测到针对人眼肌提取物或亚细胞组分的血清抗体显著滴度,或对人眼眶组织提取物产生的巨噬细胞抑制因子(MIF)。所有接受CY治疗的患者充血性改变均有改善,尽管分别有24例中有3例、20例中有11例的突眼程度和眼肌受累情况有所改善。TBAb不太可能在格雷夫斯眼病的发病机制中起作用,甲亢和眼病应被视为单独的自身免疫性疾病。眼病合并甲亢患者的平均TBAb指数高于单纯甲亢患者这一明显异常的发现,可能反映了前一组中抑制性T细胞功能存在更严重的缺陷。由于本研究未发现针对眼眶抗原的特异性免疫反应性证据,因此必须寻求其他方法来确定潜在的免疫机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验